0 Beoordelingen

ID

34272

Beschrijving

Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets; ODM derived from: https://clinicaltrials.gov/show/NCT01510522

Link

https://clinicaltrials.gov/show/NCT01510522

Trefwoorden

  1. 16-01-19 16-01-19 -
  2. 14-05-19 14-05-19 -
Houder van rechten

see on clinicaltrials.gov

Geüploaded op

16 januari 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :


    Geen commentaren

    U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

    Eligibility Diabetes Mellitus Type 2 NCT01510522

    Eligibility Diabetes Mellitus Type 2 NCT01510522

    Inclusion Criteria
    Beschrijving

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693 (Inclusion)
    diabetes mellitus type 2 diagnosed (baseline glycemia > 7,0 mmol/l (126 mg/dl) or overload glycemia > 11,0 mmol/l (198 mg/dl)
    Beschrijving

    ID.1

    Datatype

    boolean

    on treatment with metformin tablets
    Beschrijving

    ID.2

    Datatype

    boolean

    patients with at least 2 treated co-morbidities
    Beschrijving

    ID.3

    Datatype

    boolean

    established dose of metformin > 1.700 mg/day
    Beschrijving

    ID.4

    Datatype

    boolean

    age > 18 years old
    Beschrijving

    ID.5

    Datatype

    boolean

    given informed consent
    Beschrijving

    ID.6

    Datatype

    boolean

    Exclusion Criteria
    Beschrijving

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251 (Exclusion Criteria)
    patients not able to take medication orally
    Beschrijving

    ID.7

    Datatype

    boolean

    according to summary of product characteristics (smpc)
    Beschrijving

    ID.8

    Datatype

    boolean

    participating in another clinical trial 30 days prior to randomization
    Beschrijving

    ID.9

    Datatype

    boolean

    any other illness or medical or psychiatric condition, severe and uncontrolled that could interfere in the patient's participation or in the assessment of the study results
    Beschrijving

    ID.10

    Datatype

    boolean

    Similar models

    Eligibility Diabetes Mellitus Type 2 NCT01510522

    Name
    Type
    Description | Question | Decode (Coded Value)
    Datatype
    Alias
    Item Group
    C1512693 (UMLS CUI)
    ID.1
    Item
    diabetes mellitus type 2 diagnosed (baseline glycemia > 7,0 mmol/l (126 mg/dl) or overload glycemia > 11,0 mmol/l (198 mg/dl)
    boolean
    ID.2
    Item
    on treatment with metformin tablets
    boolean
    ID.3
    Item
    patients with at least 2 treated co-morbidities
    boolean
    ID.4
    Item
    established dose of metformin > 1.700 mg/day
    boolean
    ID.5
    Item
    age > 18 years old
    boolean
    ID.6
    Item
    given informed consent
    boolean
    Item Group
    C0680251 (UMLS CUI)
    ID.7
    Item
    patients not able to take medication orally
    boolean
    ID.8
    Item
    according to summary of product characteristics (smpc)
    boolean
    ID.9
    Item
    participating in another clinical trial 30 days prior to randomization
    boolean
    ID.10
    Item
    any other illness or medical or psychiatric condition, severe and uncontrolled that could interfere in the patient's participation or in the assessment of the study results
    boolean

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial